IPAMORELIN 5 MG

Kalpa Pharmaceuticals Ipamorelin 5 mg – Selective Growth Hormone Secretagogue

Kalpa Pharmaceuticals Ipamorelin 5 mg is a third-generation growth hormone-releasing peptide (GHRP) known for its selectivity and minimal impact on cortisol and prolactin. Each 2 mL vial contains 5 mg of lyophilized Ipamorelin, designed for reconstitution in research settings investigating growth hormone release mechanisms.

Unlike earlier GHRP compounds, Ipamorelin demonstrates high specificity for the ghrelin receptor (GHS-R1a) with reduced side effect profile in animal models. For researchers studying lean mass, recovery, or metabolic function, this peptide offers a distinct mechanism compared to synthetic GH. Explore similar research compounds like Sermorelin 5 mg or Tesamorelin 5 mg.

What Makes Kalpa Pharmaceuticals Ipamorelin Unique?

Ipamorelin's primary distinction lies in its selectivity. While GHRP-2 and GHRP-6 can elevate cortisol and prolactin in some research models, Ipamorelin demonstrates minimal effect on these hormones while maintaining robust GH release. This makes it a preferred tool for studies requiring isolated GH pathway activation.

For performance-focused research, Ipamorelin is often studied in combination with growth hormone-releasing hormone (GHRH) analogs like Sermorelin to evaluate synergistic effects on GH pulsatility. The 5 mg dosage provides flexibility for both acute and extended research protocols.

Benefits of Kalpa Pharmaceuticals Ipamorelin for Research

• ✔ Selective GHS-R1a agonist with minimal off-target effects
• ✔ Low impact on cortisol and prolactin in animal models
• ✔ 5 mg lyophilized powder for reconstitution flexibility
• ✔ Suitable for subcutaneous administration research
• ✔ Can be stacked with GHRH analogs for pulsatile release studies

External research on Ipamorelin's mechanisms can be explored via PubMed for peer-reviewed studies.

Product Details

Dosage & Usage Guidelines for Research

Reconstitution Protocol

• ✔ Add 2-3 mL bacteriostatic water to the 5 mg vial
• ✔ Swirl gently; do not shake
• ✔ Store reconstituted peptide at 2-8°C and use within 30 days

The standard reconstitution yields a concentration of approximately 1.67-2.5 mg/mL (1670-2500 mcg/mL). For precise dosing, researchers should calculate based on desired mcg per injection volume using appropriate syringes.

Typical Research Parameters

In animal models, Ipamorelin is often administered at dosages ranging from 200-300 mcg per injection. Due to its short half-life, twice-daily administration is common in prolonged studies. Subcutaneous injection is the standard route for systemic absorption research.

• ✔ Subcutaneous injection: 200-300 mcg once or twice daily
• ✔ Research models: Rodent dosing typically scaled by body weight
• ✔ Study duration: 4-8 weeks for chronic GH elevation studies

Combination Research

Ipamorelin is frequently studied alongside GHRH analogs like Sermorelin or modified GRF (1-29) to evaluate synergistic effects on GH pulsatility. This combination mimics natural GH release patterns more closely than either peptide alone. For stacking protocols, Sermorelin 5 mg can be reconstituted and administered concurrently.

What to Avoid During Research

• ❌ Do not use if the lyophilized cake appears discolored or collapsed
• ❌ Avoid administration with high-fat meals in oral absorption studies
• ❌ Do not mix with strong acidic or basic solutions
• ❌ Avoid repeated freeze-thaw cycles after reconstitution

Lab Testing & Batch Transparency

Lab status

COA pending release

Third-party analytical testing (COA) for Kalpa Pharmaceuticals Ipamorelin 5 mg is currently not yet available. Batch-specific assay data, purity analysis, and verification documentation will be published once released.

Testing Status

Pending

COA Availability

Not yet published

Batch Verification

In progress

Update

Coming soon

Transparency note: Kalpa Pharmaceuticals publishes batch-specific lab reports once analytical testing is completed and verified.

Awaiting COA

Shipping & Product Authenticity

What to Expect

• ✔ Orders are processed after payment confirmation
• ✔ USA Domestic shipping is typically faster when local stock is selected
• ✔ International orders include tracking, though update frequency may vary by destination
• ✔ Multiple warehouses may result in separate shipments when applicable

For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.

Storage Guidelines for Lyophilized Peptides

Store Kalpa Pharmaceuticals Ipamorelin 5 mg lyophilized powder in a cool, dry place away from direct light and moisture. Prior to reconstitution, the unopened vial should be kept at controlled room temperature (15-25°C) or refrigerated (2-8°C) for long-term storage. Do not freeze the lyophilized powder, as this may damage the peptide structure.

After reconstitution with bacteriostatic water, the solution must be stored at 2-8°C (refrigerator) and used within 30 days to maintain peptide integrity. Avoid repeated freeze-thaw cycles. Do not use if the solution appears cloudy or contains particulates, or if the vial seal is compromised.

Keep out of reach of children and unauthorized personnel. Follow standard laboratory safety protocols when handling peptides.

Proper storage conditions help maintain research-grade purity and consistent performance across the product's shelf life.

Frequently Asked Questions